These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19752758)

  • 1. Prognostic factors according to the treatment schedule in malignant pleural mesothelioma.
    Ak G; Metintas S; Metintas M; Yildirim H; Erginel S; Kurt E; Alatas F; Cadirci O
    J Thorac Oncol; 2009 Nov; 4(11):1425-30. PubMed ID: 19752758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant pleural mesothelioma: a population-based study of survival.
    Milano MT; Zhang H
    J Thorac Oncol; 2010 Nov; 5(11):1841-8. PubMed ID: 20975379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
    Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
    Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts in malignant pleural mesothelioma.
    Kaufman AJ; Pass HI
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of treatment regimens on survival in patients with malignant pleural mesothelioma.
    Abakay A; Abakay O; Tanrikulu AC; Sezgi C; Sen H; Kaya H; Kucukoner M; Kaplan MA; Celik Y; Senyigit A
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(1):19-24. PubMed ID: 23329519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor Prognostic Factors in Patients with Malignant Pleural Mesothelioma Classified as Pathological Stage IB According to the Eighth Edition TNM Classification.
    Takuwa T; Hashimoto M; Kuroda A; Nakamura A; Nakamichi T; Fukuda A; Matsumoto S; Kondo N; Hasegawa S
    Ann Surg Oncol; 2018 Jun; 25(6):1572-1579. PubMed ID: 29616420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and survival in malignant pleural mesothelioma.
    Van Gelder T; Damhuis RA; Hoogsteden HC
    Eur Respir J; 1994 Jun; 7(6):1035-8. PubMed ID: 7925870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-pathological prognostic factors in malignant pleural mesothelioma].
    Nakano K; Shiota Y; Ono T; Taniyama K; Hiramoto T; Yamakido M
    Nihon Kokyuki Gakkai Zasshi; 2007 Feb; 45(2):153-9. PubMed ID: 17352172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
    Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysis.
    Ghanim B; Hoda MA; Winter MP; Klikovits T; Alimohammadi A; Hegedus B; Dome B; Grusch M; Arns M; Schenk P; Pohl W; Zielinski C; Filipits M; Klepetko W; Berger W
    Ann Surg; 2012 Aug; 256(2):357-62. PubMed ID: 22750759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma.
    Giroux Leprieur E; Hirata T; Mo M; Chen Z; Okamoto J; Clement G; Li H; Wislez M; Jablons DM; He B
    Lung Cancer; 2014 Sep; 85(3):465-71. PubMed ID: 25023662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.
    Kao SC; Vardy J; Chatfield M; Corte P; Pavlakis N; Clarke C; van Zandwijk N; Clarke S
    Clin Lung Cancer; 2013 Jan; 14(1):70-7. PubMed ID: 22658812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term prognostic analysis of patients with malignant pleural mesothelioma].
    Cao KJ; Cui NJ
    Ai Zheng; 2005 Jan; 24(1):72-5. PubMed ID: 15642204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans.
    Liu F; Zhao B; Krug LM; Ishill NM; Lim RC; Guo P; Gorski M; Flores R; Moskowitz CS; Rusch VW; Schwartz LH
    J Thorac Oncol; 2010 Jun; 5(6):879-84. PubMed ID: 20421814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for 100 patients with malignant pleural mesothelioma.
    Gonlugur U; Gonlugur TE
    Arch Environ Occup Health; 2010; 65(2):65-9. PubMed ID: 20439224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in malignant pleural mesothelioma: role of talc pleurodesis.
    Al-Alao BS; Parissis H; Rychlik IJ; Graham A; McGuigan J
    Asian Cardiovasc Thorac Ann; 2012 Aug; 20(4):443-9. PubMed ID: 22879552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors affecting survival in malignant pleural mesothelioma: analysis of 125 subjects.
    Komurcuoglu B; Cirak AK; Kirakli SC; Polat G; Yucel N; Usluer O; Erer O; Balci G; Gayaf M; Guldaval F; Aktogu S; Guclu S; Ozsoz A; Halilcolar H
    Tumori; 2014; 100(1):55-9. PubMed ID: 24675492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.
    Fusco V; Ardizzoni A; Merlo F; Cinquegrana A; Faravelli B; De Palma M; Chessa L; Nicolò G; Serra M; Capaccio A
    Anticancer Res; 1993; 13(3):683-9. PubMed ID: 8317897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.